149 related items for PubMed ID: 24557606
21. The occurrence timeline of steroid-induced ocular hypertension and cataract in children with systemic autoimmune diseases.
Yan H, Tan X, Yu J, Liang T, Shi W, Li L, Peng C.
Int Ophthalmol; 2022 Jul; 42(7):2175-2184. PubMed ID: 35048245
[Abstract] [Full Text] [Related]
22. Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome.
Simmonds J, Grundy N, Trompeter R, Tullus K.
Arch Dis Child; 2010 Feb; 95(2):146-9. PubMed ID: 20172895
[Abstract] [Full Text] [Related]
23. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
Singh DN, Krishnamurthy S, Kamalanathan SK, Harichandrakumar KT, Sivamurukan P.
Paediatr Int Child Health; 2018 Nov; 38(4):251-260. PubMed ID: 30092157
[Abstract] [Full Text] [Related]
24. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A.
Pediatr Nephrol; 2019 May; 34(5):829-835. PubMed ID: 30194663
[Abstract] [Full Text] [Related]
25. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
Fujinaga S, Hirano D, Mizutani A, Sakuraya K, Yamada A, Sakurai S, Shimizu T.
Clin Exp Nephrol; 2017 Aug; 21(4):671-676. PubMed ID: 27558467
[Abstract] [Full Text] [Related]
26. Frequency of relapse among Nigerian children with steroid-sensitive nephrotic syndrome.
Esezobor CI, Ladapo TA, Lesi FE.
Niger J Clin Pract; 2016 Aug; 19(2):254-8. PubMed ID: 26856291
[Abstract] [Full Text] [Related]
27. Can we predict relapses in children with idiopathic steroid-sensitive nephrotic syndrome?
Mishra OP, Abhinay A, Mishra RN, Prasad R, Pohl M.
J Trop Pediatr; 2013 Oct; 59(5):343-9. PubMed ID: 23619602
[Abstract] [Full Text] [Related]
28. Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome.
Mishra OP, Thakur N, Mishra RN, Prasad R.
J Nephrol; 2012 Oct; 25(3):394-400. PubMed ID: 21928226
[Abstract] [Full Text] [Related]
29. Pharmacological validation of a feline model of steroid-induced ocular hypertension.
Bhattacherjee P, Paterson CA, Spellman JM, Graff G, Yanni JM.
Arch Ophthalmol; 1999 Mar; 117(3):361-4. PubMed ID: 10088814
[Abstract] [Full Text] [Related]
30. Relationship of steroid dose to degree of posterior subcapsular cataracts in nephrotic syndrome.
Limaye SR, Pillai S, Tina LU.
Ann Ophthalmol; 1988 Jun; 20(6):225-7. PubMed ID: 3408090
[Abstract] [Full Text] [Related]
31. Cortisone cataract in children with nephrotic syndrome.
Bachmann HJ, Schildberg P, Olbing H, Krämer D, Waubke T.
Eur J Pediatr; 1977 Mar 18; 124(4):277-83. PubMed ID: 403074
[Abstract] [Full Text] [Related]
32. A case of multiple vertebral compression fractures due to glucocorticoid-induced osteoporosis in a pediatric patient with nephrotic syndrome
.
Ashida A, Fujii Y, Matsumura H, Tamai H.
Int J Clin Pharmacol Ther; 2017 Mar 18; 55(3):264-269. PubMed ID: 27936525
[Abstract] [Full Text] [Related]
33. The use of steroid-sparing agents in steroid-sensitive nephrotic syndrome.
Abeyagunawardena AS, Dillon MJ, Rees L, van't Hoff W, Trompeter RS.
Pediatr Nephrol; 2003 Sep 18; 18(9):919-24. PubMed ID: 12883981
[Abstract] [Full Text] [Related]
34. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
Kurathong P, Jesdapatarakul S.
J Med Assoc Thai; 2000 Mar 18; 83(3):315-24. PubMed ID: 10808687
[Abstract] [Full Text] [Related]
35. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
Hama T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Sako M, Saito-Oba M, Nozu K, Shima Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
BMC Nephrol; 2018 Sep 10; 19(1):223. PubMed ID: 30200895
[Abstract] [Full Text] [Related]
36. Long-term linear growth of children with severe steroid-responsive nephrotic syndrome.
Emma F, Sesto A, Rizzoni G.
Pediatr Nephrol; 2003 Aug 10; 18(8):783-8. PubMed ID: 12811653
[Abstract] [Full Text] [Related]
37. Follow-up of linear growth of body height in children with nephrotic syndrome.
Hung YT, Yang LY.
J Microbiol Immunol Infect; 2006 Oct 10; 39(5):422-5. PubMed ID: 17066206
[Abstract] [Full Text] [Related]
38. Ocular side effects of systemic steroid therapy in renal transplant patients.
Debnath SC, Abomelha MS, Jawdat M, Chang R, Al-Khader AA.
Ann Ophthalmol; 1987 Nov 10; 19(11):435-7. PubMed ID: 3322137
[Abstract] [Full Text] [Related]
39. Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome.
Teeninga N, Kist-van Holthe JE, van Rijswijk N, de Mos NI, Hop WC, Wetzels JF, van der Heijden AJ, Nauta J.
J Am Soc Nephrol; 2013 Jan 10; 24(1):149-59. PubMed ID: 23274956
[Abstract] [Full Text] [Related]
40. Long-term results of two unconventional agents in steroid-dependent nephrotic children.
Donia AF, Ammar HM, El-Agroudy Ael-B, Moustafa Fel-H, Sobh MA.
Pediatr Nephrol; 2005 Oct 10; 20(10):1420-5. PubMed ID: 16047223
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
